The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 tablet contains active substance: thiotriazoline 0.1 g.
Hepatitis of various origin, cholecystitis, myocarditis, cardiomyopathy associated with metabolic disorders, ischemic heart disease (as an adjunctive treatment) and postoperative complications.
If you have information about any adverse effects or other drug-related problems, please fill in the form